Unichem Laboratories Limited has informed the Exchange about Shareholders meeting
UNICHEMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Unichem Laboratories held its 62nd Annual General Meeting on 4th August 2025 via video conference, chaired by Dr. Prakash A. Mody, with all directors in attendance. The Managing Director addressed shareholders on the current market scenario and the company's performance, while the Statutory and Secretarial Auditors' reports were noted to have no qualifications. Seven resolutions were tabled, including adoption of the audited standalone and consolidated financial statements for FY ended 31st March 2025, re-appointment of Dr. Prakash Mody as a director retiring by rotation, approval of material related party transactions with holding company Ipca Laboratories Limited and wholly owned US subsidiary Unichem Pharmaceuticals (USA) Inc., appointment of Alwyn Jay and Co. as Secretarial Auditors for five years, and ratification of Cost Auditor remuneration. Voting was conducted electronically through the NSDL platform with results to be announced within the stipulated time.
This is a routine procedural disclosure of AGM proceedings with no material price-moving information; investors should watch for the e-voting results and any subsequent announcements on the related party transactions with Ipca Laboratories.